Enliven Therapeutics, Inc. $ELVN is Seven Fleet Capital Management LP's 3rd Largest Position
MarketBeat
Seven Fleet Capital Management LP Grows Stock Holdings in Cytokinetics, Incorporated $CYTK
MarketBeat
Seven Fleet Capital Management LP Has $6.78 Million Holdings in Dianthus Therapeutics, Inc. $DNTH
MarketBeat
Seven Fleet Capital Management LP Makes New Investment in Minerva Neurosciences, Inc $NERV
MarketBeat
29,300 Shares in Celldex Therapeutics, Inc. $CLDX Purchased by Seven Fleet Capital Management LP
MarketBeat
120,400 Shares in Replimune Group, Inc. $REPL Purchased by Seven Fleet Capital Management LP
MarketBeat
82,890 Shares in Corvus Pharmaceuticals, Inc. $CRVS Acquired by Seven Fleet Capital Management LP
MarketBeat
Seven Fleet Capital Management LP Has $2.79 Million Stock Position in Ascendis Pharma A/S $ASND
MarketBeat
Seven Fleet Capital Management LP Has $4.79 Million Position in Abivax SA Sponsored ADR $ABVX
MarketBeat
Seven Fleet Capital Management LP Raises Stock Position in CytomX Therapeutics, Inc. $CTMX
MarketBeat
